Events in our system are self-managed.  Group and event managers are encouraged to review privacy and security settings, and adjust them if needed.  If you need assistance please contact Indico Support - contact Help at bottom of page. https://learn.getindico.io/categories/managing/

19–24 Oct 2025
Chateau Fairmont Whistler
America/Vancouver timezone

The TATTOOS Facility

20 Oct 2025, 16:20
20m
MacDonald AB (Fairmont Chateau Whistler)

MacDonald AB

Fairmont Chateau Whistler

Oral contributed talk Isotope production, target, and ion source techniques Facilities II

Speaker

Stuart Warren (Paul Schreere Institute)

Description

The TATTOOS Facility

Stuart Warren*, R. Eichler, M. Hartmann, A. Ivanov, S. Jollet, H. Jöhri, R. Hübscher, D. Kiselev, D. Laube, R. Martinie, M. Mostamand, D. Reggiani, J. Snuverink, N. van der Meulen, U. Wellenkam

Paul Scherrer Institute, PSI Forschungsstrasse 111, 5232 Villigen PSI, Switzerland

Stuart.warren@psi.ch

TATTOOS (Targeted Alpha Tumour Therapy and Other Oncological Solutions) is the next major installation at the Paul Scherrer Institute as part of the IMPACT project[1]. It envisages the use of the high intensity high energy proton beam from the ring cyclotron (HIPA, 590MeV 2.4 mA H+) to impinge on high Z targets for spallation produced radionuclides. The facility is, by design, a high throughput machine, with expected 100 uA proton beams impacting the target, producing a high yield of isotopes (>GBq Tb149) via spallation, online mass separation and laser ionization with less than 2% neighbouring mass contamination.

Here, we present the current status of the designs and layout for the core features of the facility; the high throughput electromagnetic separator with the moderate resolution of 3000 for typical surface source ion beams, the subsequent ion beamline systems and services, proposed collections, and proposed layout in the confined space of the site.

The facility aims to be the silver bullet in the production bottleneck of radionuclides for oncological solutions, bridging the gap between the technology and the clinical trial solution with medically relevant quantities of radionuclides.

[1] Eichler, R., Kiselev, D., Koschik, A., Knecht, A., van der Meulen, N., et Al (2022). IMPACT conceptual design report. (PSI Bericht, Report No.: 22-01). Paul Scherrer Institute.

Email address stuart.warren@psi.ch
Supervisor's Name Robert Eichler
Supervisor's email robert.eichler@psi.ch
Funding Agency PSI
Classification Isotope production, target, and ion source techniques

Primary author

Stuart Warren (Paul Schreere Institute)

Co-authors

Aleksandar Ivanov Stoyanov (Paul Scherrer Institut) Daniel Laube (Paul Scherrer Institut) Daniela Kiselev (Paul Scherrer Institut) Davide Reggiani Haimo Jöhri (Paul Scherrer Institut) Jochem Snuverink (Paul Scherrer Institut) Marco Hartmann (TRIUMF) Maryam Mostamand (Paul Scherrer Institut) Nicholas Philip van der Meulen (Paul Scherrer Institut) Remi Martinie (Paul Scherrer Institut) Rico Hübscher (Paul Scherrer Institut) Robert Eichler (Paul Scherrer Institut) Sven Jollet (Paul Scherrer Institut) Ulrich Wellenkamp (Paul Scherrer Institut)

Presentation materials